Staphylococcus aureus Panton-Valentine Leukocidin Is a Very Potent Cytotoxic Factor for Human Neutrophils

The role of the pore-forming Staphylococcus aureus toxin Panton-Valentine leukocidin (PVL) in severe necrotizing diseases is debated due to conflicting data from epidemiological studies of community-associated methicillin-resistant S. aureus (CA-MRSA) infections and various murine disease-models. In this study, we used neutrophils isolated from different species to evaluate the cytotoxic effect of PVL in comparison to other staphylococcal cytolytic components. Furthermore, to study the impact of PVL we expressed it heterologously in a non-virulent staphylococcal species and examined pvl-positive and pvl-negative clinical isolates as well as the strain USA300 and its pvl-negative mutant. We demonstrate that PVL induces rapid activation and cell death in human and rabbit neutrophils, but not in murine or simian cells. By contrast, the phenol-soluble modulins (PSMs), a newly identified group of cytolytic staphylococcal components, lack species-specificity. In general, after phagocytosis of bacteria different pvl-positive and pvl-negative staphylococcal strains, expressing a variety of other virulence factors (such as surface proteins), induced cell death in neutrophils, which is most likely associated with the physiological clearing function of these cells. However, the release of PVL by staphylococcal strains caused rapid and premature cell death, which is different from the physiological (and programmed) cell death of neutrophils following phagocytosis and degradation of virulent bacteria. Taken together, our results question the value of infection-models in mice and non-human primates to elucidate the impact of PVL. Our data clearly demonstrate that PVL acts differentially on neutrophils of various species and suggests that PVL has an important cytotoxic role in human neutrophils, which has major implications for the pathogenesis of CA-MRSA infections.

[1]  F. DeLeo,et al.  Host defense and pathogenesis in Staphylococcus aureus infections. , 2009, Infectious disease clinics of North America.

[2]  G. Storch,et al.  Virulence gene expression in human community-acquired Staphylococcus aureus infection. , 2009, The Journal of infectious diseases.

[3]  O. Schneewind,et al.  Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. , 2008, The Journal of infectious diseases.

[4]  Adeline R. Whitney,et al.  Contribution of Panton-Valentine Leukocidin in Community-Associated Methicillin-Resistant Staphylococcus aureus Pathogenesis , 2008, PloS one.

[5]  F. Lowy,et al.  Pathogenesis of methicillin-resistant Staphylococcus aureus infection. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  M. Kollef,et al.  Pneumonia caused by methicillin-resistant Staphylococcus aureus. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  K. Carroll,et al.  In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Kennedy,et al.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA , 2007, Nature Medicine.

[9]  O. Schneewind,et al.  Poring over pores: α-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia , 2007, Nature Medicine.

[10]  E. Delong,et al.  Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia , 2007, Science.

[11]  P. Riley,et al.  CORRECTION , 2006, Journal of Clinical Pathology.

[12]  O. Schneewind,et al.  Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. , 2007, Nature medicine.

[13]  P. François,et al.  A global view of Staphylococcus aureus whole genome expression upon internalization in human epithelial cells , 2007, BMC Genomics.

[14]  Adeline R. Whitney,et al.  Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? , 2006, The Journal of infectious diseases.

[15]  O. Schneewind,et al.  Surface Proteins and Exotoxins Are Required for the Pathogenesis of Staphylococcus aureus Pneumonia , 2006, Infection and Immunity.

[16]  A. Prince,et al.  Staphylococcus aureus Protein A Activates TNFR1 Signaling through Conserved IgG Binding Domains* , 2006, Journal of Biological Chemistry.

[17]  S. Ray,et al.  Emergence of Community-Acquired Methicillin-Resistant Staphylococcus aureus USA 300 Clone as the Predominant Cause of Skin and Soft-Tissue Infections , 2006, Annals of Internal Medicine.

[18]  Fred C Tenover,et al.  Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. , 2006, The Journal of infectious diseases.

[19]  T. Foster Immune evasion by staphylococci , 2005, Nature Reviews Microbiology.

[20]  F. Vandenesch,et al.  Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils. , 2005, The Journal of clinical investigation.

[21]  F. DeLeo,et al.  Differential Distribution and Expression of Panton-Valentine Leucocidin among Community-Acquired Methicillin-Resistant Staphylococcus aureus Strains , 2005, Journal of Clinical Microbiology.

[22]  K. Schulze-Osthoff,et al.  Staphylococcus aureusα‐toxin induces apoptosis in peripheral blood mononuclear cells: role of endogenous tumour necrosis factor‐α and the mitochondrial death pathway , 2003, Cellular microbiology.

[23]  Bin Zhang,et al.  Elucidation of Molecular Events Leading to Neutrophil Apoptosis following Phagocytosis , 2003, Journal of Biological Chemistry.

[24]  P. Vanhems,et al.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients , 2002, The Lancet.

[25]  O. Kretz,et al.  Mice with an Increased Glucocorticoid Receptor Gene Dosage Show Enhanced Resistance to Stress and Endotoxic Shock , 2000, Molecular and Cellular Biology.

[26]  K. Krause,et al.  Heterologously Expressed Staphylococcus aureusFibronectin-Binding Proteins Are Sufficient for Invasion of Host Cells , 2000, Infection and Immunity.

[27]  J J Sixma,et al.  Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. , 2000, Blood.

[28]  F. Vandenesch,et al.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  S. Szmigielski,et al.  Leukocidal toxins of staphylococci. , 1999, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

[30]  A. Conde Staphylococcus aureus infections. , 1998, The New England journal of medicine.

[31]  Extracellular enzymes. , 1995, Environmental science & technology.

[32]  R. Proctor,et al.  Gentamicin-resistant menadione and hemin auxotrophic Staphylococcus aureus persist within cultured endothelial cells. , 1994, The Journal of infectious diseases.

[33]  S Bhakdi,et al.  Alpha-toxin of Staphylococcus aureus. , 1991, Microbiological reviews.

[34]  F. Götz,et al.  Improvements of protoplast transformation in Staphylococcus carnosus , 1987 .

[35]  A. Woodin Purification of the two components of leucocidin from Staphylococcus aureus. , 1960, The Biochemical journal.